Abiopharma

New Form 6-K - Alpha Tau Medical Ltd. Filed: 2025-09-02 AccNo: 0001213900-25-082941 Size: 33 KB

New Form 8-K - Coya Therapeutics, Inc. Filed: 2025-09-02 AccNo: 0001193125-25-193450 Size: 140 KB Item 8.01: Other Events

New Form SC 14D9/A - Y-mAbs Therapeutics, Inc. Filed: 2025-09-02 AccNo: 0001104659-25-086040 Size: 16 KB

New Form 8-K - Enveric Biosciences, Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026143 Size: 228 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference

PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference

Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial

Press Release: DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference

New Form 425 - Gryphon Digital Mining, Inc. Filed: 2025-09-02 AccNo: 0001213900-25-082934 Size: 694 KB

SeaStar Medical - SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival